Biological Prognostic Markers in Diffuse Large B-Cell Lymphoma
Author:
Affiliation:
1. Department of Pathology and Microbiology at the Nebraska Medical Center, Omaha, Nebraska
2. Department of Internal Medicine, Clinical Hospital Dubrava, Zagreb, Croatia.
Publisher
SAGE Publications
Subject
Oncology,Hematology,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/107327481201900306
Reference108 articles.
1. SwerdlowS.H., CampoE., HarrisN.L., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC; 2008.
2. Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium
3. A Predictive Model for Aggressive Non-Hodgkin's Lymphoma
4. Diffuse Large Cell Lymphomas: Identification of Prognostic Factors and Validation of the International Non-Hodgkin’s Lymphoma Prognostic Index
5. International prognostic index-based outcomes for diffuse large B-cell lymphomas
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. CC chemokine receptor 2 (CCR2) expression promotes diffuse large B-Cell lymphoma survival and invasion;Laboratory Investigation;2022-12
2. Adherence to guidelines-recommended diagnostic testing was associated with overall survival in patients with diffuse large B-cell lymphoma after rituximab-based treatment: an observational cohort study;Journal of Cancer Research and Clinical Oncology;2022-08-17
3. The Era of Genomic Research for Lymphoma: Looking Back and Forward;Hemato;2022-08-15
4. Altered pathways and targeted therapy in double hit lymphoma;Journal of Hematology & Oncology;2022-03-18
5. Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial;Journal for ImmunoTherapy of Cancer;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3